Navigation Links
President Obama calls for increased investment in science, including biomedical research
Date:1/26/2011

Bethesda, MD - Last night, in his State of the Union address, President Barack Obama presented the nation with a vision of a better future through investment in education, infrastructure, and research. Recognizing the role that innovation has played in this nation's history and the promise that it holds for addressing the many challenges we face, he stated that "maintaining our leadership in research and technology is crucial to America's success."

William T. Talman, MD, President of the Federation of American Societies for Experimental Biology (FASEB) responded, "we wholeheartedly agree with the President's emphasis on education and research. We are especially pleased to hear that he will make investment in biomedical research a priority in his 2012 budget. This will promote innovation, create new technologies, improve health, and revitalize the economy. It is also gratifying to the thousands of young Americans who have dedicated themselves to pursuit of careers in science and engineering, and this will inspire others to follow their lead. They will know that the nation values their contributions."

Talman also praised the President's emphasis on basic research, which recognized the irreplaceable role of public funding for the investigation of fundamental scientific principles. "This work leads to dramatic breakthroughs but does not receive sufficient support from the private sector because its applications are not always immediately apparent. FASEB will enthusiastically support President Obama's vision," Talman added.


'/>"/>

Contact: Lawrence Green
lgreen@FASEB.org
301-634-7335
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. Forest Service researcher receives prestigious Presidential award
2. Entrust President and CEO Bill Conner Addresses Global Dignitaries During INTERPOL 79th General Assembly
3. Brookhaven chemist Jacob Hooker receives Presidential Early Career Award
4. ClinOps Announces Appointment of New President and CEO
5. Congressman, CSHL president urge quick action to reverse judicial embryonic stem cell research ban
6. SRI International President and CEO Curtis R. Carlson Named to National Advisory Council on Innovation and Entrepreneurship
7. UCLAs James Liao receives Presidential Green Chemistry Challenge Award from EPA
8. Suzanne Cory becomes first-elected woman president of AAS
9. Entertainment Studios Networks Names Janice Arouh President, Domestic Distribution and Marketing
10. BCIU Applauds Presidential Summit on Entrepreneurship, Sees Efforts Generating Goodwill, Partnerships and Jobs
11. Tel Aviv University President Co-authors Important Paper Unraveling the Effect of Spatial Organization on Intracellular Chemistry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)...  In vitro diagnostic (IVD) companies were very active ... and Kalorama Information expects that trend to continue – ... Generally, uncertainty in reimbursement and healthcare reform in ... the acquisitions landscape. Instead of looking to buy technology, ... outside of their home country and also to increase ...
(Date:1/12/2017)... 12, 2017 A new report by Allied Market Research, titled, ... biometric technology market is expected to generate revenue of $10.72 billion by 2022, with ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) In the ...
(Date:1/6/2017)... , Jan. 5, 2017  Delta ID Inc., a ... scanning technology for automotive at CES® 2017. Delta ID ... ) to demonstrate the use of iris scanning as ... authenticate the driver in a car, and as a ... driving experience. Delta ID and Gentex will ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... Md. and GAITHERSBURG, Md. ... (NYSE MKT: PIP) and Altimmune, Inc., a privately-held ... signing of a definitive agreement for the merger ... Altimmune,s current investors include Novartis Venture Fund, HealthCap, ... will be a fully-integrated and diversified immunotherapeutics company ...
(Date:1/19/2017)... -- AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), a ... a majority-owned subsidiary of Intrexon Corporation (NYSE: ... of its common shares on the NASDAQ Stock Market ... "AquaBounty,s listing on NASDAQ represents an important milestone for ... U.S. markets as we advance plans for commercial production ...
(Date:1/19/2017)... Linda, Ca (PRWEB) , ... January 18, 2017 ... ... virtual events for tech innovators, engineers, and scientists from around the world, was ... American News. The awards program is based entirely on merit and decided upon ...
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita Clinical Research ... drug and device development, and Prism Clinical Research , a leader in ... Verified Clinical Trials (VCT) has been selected by both companies as ...
Breaking Biology Technology: